ATE197764T1 - Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält. - Google Patents

Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.

Info

Publication number: ATE197764T1
Authority: AT; Austria
Prior art keywords: insulin; mammals; treatment; composition; deficiency
Prior art date: 1991-05-24

Application number

AT92913644T

Other languages

English (en)

Inventor

Timothy J Rink

Andrew A Young

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-24

Filing date

1992-05-23

Publication date

2000-12-15

1992-05-23 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

2000-12-15 Application granted granted Critical

2000-12-15 Publication of ATE197764T1 publication Critical patent/ATE197764T1/de

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 6
102000004877 Insulin Human genes 0.000 title abstract 3
108090001061 Insulin Proteins 0.000 title abstract 3
241000124008 Mammalia Species 0.000 title abstract 3
229940125396 insulin Drugs 0.000 title abstract 3
102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 2
108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000007812 deficiency Effects 0.000 title 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
229920002527 Glycogen Polymers 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
239000008103 glucose Substances 0.000 abstract 2
229940096919 glycogen Drugs 0.000 abstract 2
238000000338 in vitro Methods 0.000 abstract 2
238000010348 incorporation Methods 0.000 abstract 2
210000002027 skeletal muscle Anatomy 0.000 abstract 2
238000000034 method Methods 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT92913644T 1991-05-24 1992-05-23 Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält. ATE197764T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70499591A	1991-05-24	1991-05-24
PCT/US1992/004351 WO1992020366A1 (en)	1991-05-24	1992-05-23	Insulin and amylin containing composition for the treatment of insulin deficient mammals

Publications (1)

Publication Number	Publication Date
ATE197764T1 true ATE197764T1 (de)	2000-12-15

Family

ID=24831674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92913644T ATE197764T1 (de)	1991-05-24	1992-05-23	Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.

Country Status (11)

Country	Link
EP (1)	EP0586592B1 (de)
JP (1)	JPH06510753A (de)
AT (1)	ATE197764T1 (de)
AU (2)	AU2169392A (de)
CA (1)	CA2109604A1 (de)
DE (1)	DE69231583T2 (de)
DK (1)	DK0586592T3 (de)
ES (1)	ES2153828T3 (de)
GR (1)	GR3035287T3 (de)
SG (1)	SG44838A1 (de)
WO (1)	WO1992020366A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2109794A1 (en) *	1991-05-24	1992-11-26	Timothy J. Rink	Amylin and possibly insulin containing composition for the treatment of anorexia and related states
CA2369839A1 (en) *	1999-06-25	2001-01-04	Minimed, Inc.	Compositions of insulin and insulin-related peptide for treating diabetes
AU2002248464A1 (en)	2001-02-21	2002-09-12	Medtronic Minimed, Inc.	Stabilized insulin formulations
US6737401B2 (en)	2001-06-28	2004-05-18	Metronic Minimed, Inc.	Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
GB8915712D0 (en) *	1989-07-08	1989-08-31	Macintyre Iain	Medical treatment

1992
- 1992-05-23 WO PCT/US1992/004351 patent/WO1992020366A1/en not_active Ceased
- 1992-05-23 EP EP92913644A patent/EP0586592B1/de not_active Expired - Lifetime
- 1992-05-23 SG SG1996008450A patent/SG44838A1/en unknown
- 1992-05-23 AU AU21693/92A patent/AU2169392A/en not_active Abandoned
- 1992-05-23 ES ES92913644T patent/ES2153828T3/es not_active Expired - Lifetime
- 1992-05-23 CA CA002109604A patent/CA2109604A1/en not_active Abandoned
- 1992-05-23 JP JP5500328A patent/JPH06510753A/ja active Pending
- 1992-05-23 DE DE69231583T patent/DE69231583T2/de not_active Expired - Lifetime
- 1992-05-23 AT AT92913644T patent/ATE197764T1/de active
- 1992-05-23 DK DK92913644T patent/DK0586592T3/da active
1996
- 1996-08-07 AU AU61964/96A patent/AU6196496A/en not_active Abandoned
2001
- 2001-01-24 GR GR20010400101T patent/GR3035287T3/el unknown

Also Published As

Publication number	Publication date
ES2153828T3 (es)	2001-03-16
DE69231583T2 (de)	2001-03-29
DE69231583D1 (de)	2001-01-04
DK0586592T3 (da)	2000-12-27
EP0586592A1 (de)	1994-03-16
AU6196496A (en)	1996-10-10
SG44838A1 (en)	1997-12-19
WO1992020366A1 (en)	1992-11-26
CA2109604A1 (en)	1992-11-26
EP0586592B1 (de)	2000-11-29
JPH06510753A (ja)	1994-12-01
AU2169392A (en)	1992-12-30
GR3035287T3 (en)	2001-04-30

Similar Documents

Publication	Publication Date	Title
MY132626A (en)	2007-10-31	CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE105482T1 (de)	1994-05-15	Behandlung von krebs mit somatostatin und mit analogen davon.
AU2118488A (en)	1989-02-23	Improvements in or relating to methods of treating damaged skin
ATE151282T1 (de)	1997-04-15	Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
GR3019315T3 (en)	1996-06-30	Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
HU905682D0 (en)	1991-03-28	Early ejaculation treatment by using sertraline
DE69328186D1 (de)	2000-04-27	Zusammensetzung zur behandlung der parkinson-krankheit
GR1002802B (el)	1997-11-10	Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
DE69521536D1 (de)	2001-08-09	Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
ES478967A1 (es)	1980-08-16	Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ES2002083A6 (es)	1988-07-01	Un metodo para preparar derivados de piroglutamida
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
MX9701187A (es)	1997-05-31	Nuevas lactamas naftofusionadas n-substituidas.
IL126235A (en)	2003-02-12	Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
IL88971A0 (en)	1989-08-15	Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ATE240116T1 (de)	2003-05-15	Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie
EP0313654A4 (de)	1990-01-11	Arzneimittel für die prophylaxe und die behandlung von leberkrankheiten.
DE69231583D1 (de)	2001-01-04	Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
OA09121A (fr)	1991-10-31	Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.
GR3001793T3 (en)	1992-11-23	Polyprenyl alcohol-containing injections and use thereof
HUT61485A (en)	1993-01-28	Process for producing drug composition suitable for treating thrombocytopenia
EP0330756A3 (en)	1989-11-29	Thienotricyclics for the treatment of bronchial diseases
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
JPS5587713A (en)	1980-07-02	Weakly acidic nursery powder

Legal Events

Date	Code	Title	Description
2001-03-15	UEP	Publication of translation of european patent specification